{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T07:29:36Z","timestamp":1792999776255,"version":"4.5.0"},"reference-count":67,"publisher":"American Medical Association (AMA)","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA"],"published-print":{"date-parts":[[2018,8,28]]},"DOI":"10.1001\/jama.2018.11406","type":"journal-article","created":{"date-parts":[[2018,8,30]],"date-time":"2018-08-30T19:31:05Z","timestamp":1535657465000},"page":"815","source":"Crossref","is-referenced-by-count":572,"title":["Diagnosis and Pharmacotherapy of Alcohol Use Disorder"],"prefix":"10.1001","volume":"320","author":[{"given":"Henry R.","family":"Kranzler","sequence":"first","affiliation":[{"name":"Department of Psychiatry, University of Pennsylvania Perelman School of Medicine, Philadelphia"},{"name":"Crescenz Veterans Affairs Medical Center, Philadelphia, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Soyka","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, Ludwig-Maximilians-University, Munich, Germany"},{"name":"Medicalpark Chiemseeblick, Bernau-Felden, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"8","key":"jrv180006r6","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1001\/jamapsychiatry.2015.0584","article-title":"Epidemiology of DSM-5 alcohol use disorder: results from the National Epidemiologic Survey on Alcohol and Related Conditions III.","volume":"72","author":"Grant","year":"2015","journal-title":"JAMA Psychiatry"},{"issue":"4","key":"jrv180006r7","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.1111\/acer.12331","article-title":"Burden of disease associated with alcohol use disorders in the United States.","volume":"38","author":"Rehm","year":"2014","journal-title":"Alcohol Clin Exp Res"},{"issue":"2","key":"jrv180006r8","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1093\/alcalc\/agv088","article-title":"Alcohol dependence, co-occurring conditions and attributable burden.","volume":"51","author":"Odlaug","year":"2016","journal-title":"Alcohol Alcohol"},{"issue":"2","key":"jrv180006r10","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1111\/add.2013.108.issue-2","article-title":"Meta-analysis of naltrexone and acamprosate for treating alcohol use disorders: when are these medications most helpful?","volume":"108","author":"Maisel","year":"2013","journal-title":"Addiction"},{"issue":"18","key":"jrv180006r11","doi-asserted-by":"publisher","first-page":"1889","DOI":"10.1001\/jama.2014.3628","article-title":"Pharmacotherapy for adults with alcohol use disorders in outpatient settings: a systematic review and meta-analysis.","volume":"311","author":"Jonas","year":"2014","journal-title":"JAMA"},{"issue":"6","key":"jrv180006r12","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1111\/add.12875","article-title":"The efficacy of acamprosate and naltrexone in the treatment of alcohol dependence, Europe versus the rest of the world: a meta-analysis.","volume":"110","author":"Donoghue","year":"2015","journal-title":"Addiction"},{"issue":"2","key":"jrv180006r13","doi-asserted-by":"publisher","first-page":"e87366","DOI":"10.1371\/journal.pone.0087366","article-title":"Disulfiram efficacy in the treatment of alcohol dependence: a meta-analysis.","volume":"9","author":"Skinner","year":"2014","journal-title":"PLoS One"},{"issue":"12","key":"jrv180006r14","first-page":"CD001867","article-title":"Opioid antagonists for alcohol dependence.","author":"R\u00f6sner","year":"2010","journal-title":"Cochrane Database Syst Rev"},{"issue":"9","key":"jrv180006r15","first-page":"CD004332","article-title":"Acamprosate for alcohol dependence.","author":"R\u00f6sner","year":"2010","journal-title":"Cochrane Database Syst Rev"},{"issue":"12","key":"jrv180006r16","doi-asserted-by":"publisher","first-page":"e1001924","DOI":"10.1371\/journal.pmed.1001924","article-title":"Risks and benefits of nalmefene in the treatment of adult alcohol dependence: a systematic literature review and meta-analysis of published and unpublished double-blind randomized controlled trials.","volume":"12","author":"Palpacuer","year":"2015","journal-title":"PLoS Med"},{"issue":"7","key":"jrv180006r17","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1016\/j.euroneuro.2018.03.017","article-title":"Efficacy, tolerability, and safety of low-dose and high-dose baclofen in the treatment of alcohol dependence: a systematic review and meta-analysis.","volume":"28","author":"Pierce","year":"2018","journal-title":"Eur Neuropsychopharm"},{"issue":"6","key":"jrv180006r18","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.1111\/acer.2014.38.issue-6","article-title":"A meta-analysis of topiramate\u2019s effects for individuals with alcohol use disorders.","volume":"38","author":"Blodgett","year":"2014","journal-title":"Alcohol Clin Exp Res"},{"issue":"13","key":"jrv180006r19","doi-asserted-by":"publisher","first-page":"1617","DOI":"10.1001\/jama.293.13.1617","article-title":"Efficacy and tolerability of long-acting injectable naltrexone for alcohol dependence: a randomized controlled trial.","volume":"293","author":"Garbutt","year":"2005","journal-title":"JAMA"},{"issue":"1","key":"jrv180006r20","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1001\/jamainternmed.2013.11950","article-title":"Gabapentin treatment for alcohol dependence: a randomized clinical trial.","volume":"174","author":"Mason","year":"2014","journal-title":"JAMA Intern Med"},{"issue":"4","key":"jrv180006r21","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1517\/14740338.2015.1011619","article-title":"Safety and tolerability of as-needed nalmefene in the treatment of alcohol dependence: results from the phase III clinical programme.","volume":"14","author":"van den Brink","year":"2015","journal-title":"Expert Opin Drug Saf"},{"key":"jrv180006r22","first-page":"CD007938","article-title":"Gabapentin for chronic neuropathic pain in adults.","volume":"6","author":"Wiffen","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"issue":"11","key":"jrv180006r23","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.1001\/jama.1986.03380110055026","article-title":"Disulfiram treatment of alcoholism. a Veterans Administration cooperative study.","volume":"256","author":"Fuller","year":"1986","journal-title":"JAMA"},{"issue":"7","key":"jrv180006r24","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1111\/add.13787","article-title":"The safety and efficacy of baclofen to reduce alcohol use in veterans with chronic hepatitis C: a randomized controlled trial.","volume":"112","author":"Hauser","year":"2017","journal-title":"Addiction"},{"issue":"14","key":"jrv180006r25","doi-asserted-by":"publisher","first-page":"1641","DOI":"10.1001\/jama.298.14.1641","article-title":"Topiramate for treating alcohol dependence: a randomized controlled trial.","volume":"298","author":"Johnson","year":"2007","journal-title":"JAMA"},{"issue":"5","key":"jrv180006r26","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1017\/S0033291714002165","article-title":"The heritability of alcohol use disorders: a meta-analysis of twin and adoption studies.","volume":"45","author":"Verhulst","year":"2015","journal-title":"Psychol Med"},{"issue":"5","key":"jrv180006r27","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1016\/S0306-4603(01)00204-0","article-title":"Adverse childhood experiences and personal alcohol abuse as an adult.","volume":"27","author":"Dube","year":"2002","journal-title":"Addict Behav"},{"issue":"1","key":"jrv180006r30","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1517\/13543784.2014.954037","article-title":"Investigational therapies for the pharmacological treatment of alcoholism.","volume":"24","author":"Hillemacher","year":"2015","journal-title":"Expert Opin Investig Drugs"},{"issue":"3","key":"jrv180006r31","doi-asserted-by":"crossref","first-page":"210","DOI":"10.7326\/0003-4819-159-3-201308060-00652","article-title":"Screening and behavioral counseling interventions in primary care to reduce alcohol misuse: US Preventive Services Task Force recommendation statement.","volume":"159","author":"Moyer","year":"2013","journal-title":"Ann Intern Med"},{"issue":"1","key":"jrv180006r32","first-page":"16","article-title":"Vital signs: communication between health professionals and their patients about alcohol use\u201444 states and the District of Columbia, 2011.","volume":"63","author":"McKnight-Eily","year":"2014","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"4","key":"jrv180006r33","doi-asserted-by":"publisher","first-page":"423","DOI":"10.15288\/jsa.1995.56.423","article-title":"The Alcohol Use Disorders Identification Test (AUDIT): validation of a screening instrument for use in medical settings.","volume":"56","author":"Bohn","year":"1995","journal-title":"J Stud Alcohol"},{"issue":"16","key":"jrv180006r34","doi-asserted-by":"publisher","first-page":"1789","DOI":"10.1001\/archinte.158.16.1789","article-title":"The AUDIT alcohol consumption questions (AUDIT-C): an effective brief screening test for problem drinking: Ambulatory Care Quality Improvement Project (ACQUIP): Alcohol Use Disorders Identification Test.","volume":"158","author":"Bush","year":"1998","journal-title":"Arch Intern Med"},{"issue":"12","key":"jrv180006r35","doi-asserted-by":"publisher","first-page":"879","DOI":"10.7326\/0003-4819-149-12-200812160-00007","article-title":"Meta-analysis: are 3 questions enough to detect unhealthy alcohol use?","volume":"149","author":"Kriston","year":"2008","journal-title":"Ann Intern Med"},{"issue":"1","key":"jrv180006r36","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1176\/appi.ajp.2017.1750101","article-title":"The American Psychiatric Association practice guideline for the pharmacological treatment of patients with alcohol use disorder.","volume":"175","author":"Reus","year":"2018","journal-title":"Am J Psychiatry"},{"issue":"7","key":"jrv180006r38","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1046\/j.1360-0443.2003.00438.x","article-title":"How important is treatment? one-year outcomes of treated and untreated alcohol-dependent individuals.","volume":"98","author":"Weisner","year":"2003","journal-title":"Addiction"},{"issue":"1-3","key":"jrv180006r39","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/j.drugalcdep.2008.07.018","article-title":"Alcohol and opioid dependence medications: prescription trends, overall and by physician specialty.","volume":"99","author":"Mark","year":"2009","journal-title":"Drug Alcohol Depend"},{"issue":"7","key":"jrv180006r40","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1176\/appi.ps.201000553","article-title":"Pharmacotherapy of alcohol use disorders by the Veterans Health Administration: patterns of receipt and persistence.","volume":"63","author":"Harris","year":"2012","journal-title":"Psychiatr Serv"},{"issue":"1","key":"jrv180006r41","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1176\/ajp.152.1.45","article-title":"Alcoholism and affective disorder: clinical course of depressive symptoms.","volume":"152","author":"Brown","year":"1995","journal-title":"Am J Psychiatry"},{"issue":"6","key":"jrv180006r42","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1176\/appi.ajp.2009.08060852","article-title":"A double-blind, placebo-controlled trial combining sertraline and naltrexone for treating co-occurring depression and alcohol dependence.","volume":"167","author":"Pettinati","year":"2010","journal-title":"Am J Psychiatry"},{"key":"jrv180006r43","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.phrs.2018.04.024","article-title":"Drug-drug interactions in the treatment for alcohol use disorders: a comprehensive review.","volume":"133","author":"Guerzoni","year":"2018","journal-title":"Pharmacol Res"},{"issue":"1","key":"jrv180006r44","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/S0740-5472(01)00210-0","article-title":"Reduced-risk drinking as a treatment goal: what clinicians need to know.","volume":"22","author":"Ambrogne","year":"2002","journal-title":"J Subst Abuse Treat"},{"issue":"12","key":"jrv180006r45","doi-asserted-by":"publisher","first-page":"2022","DOI":"10.1111\/acer.2010.34.issue-12","article-title":"Percentage of subjects with no heavy drinking days: evaluation as an efficacy endpoint for alcohol clinical trials.","volume":"34","author":"Falk","year":"2010","journal-title":"Alcohol Clin Exp Res"},{"issue":"17","key":"jrv180006r46","doi-asserted-by":"publisher","first-page":"2003","DOI":"10.1001\/jama.295.17.2003","article-title":"Combined pharmacotherapies and behavioral interventions for alcohol dependence: the COMBINE study: a randomized controlled trial.","volume":"295","author":"Anton","year":"2006","journal-title":"JAMA"},{"issue":"5","key":"jrv180006r48","doi-asserted-by":"publisher","first-page":"427","DOI":"10.2165\/00002018-199920050-00003","article-title":"Safety issues concerning the use of disulfiram in treating alcohol dependence.","volume":"20","author":"Chick","year":"1999","journal-title":"Drug Saf"},{"issue":"11","key":"jrv180006r49","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1001\/archpsyc.1992.01820110045007","article-title":"Naltrexone and coping skills therapy for alcohol dependence: a controlled study.","volume":"49","author":"O\u2019Malley","year":"1992","journal-title":"Arch Gen Psychiatry"},{"issue":"11","key":"jrv180006r50","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1001\/archpsyc.1992.01820110040006","article-title":"Naltrexone in the treatment of alcohol dependence.","volume":"49","author":"Volpicelli","year":"1992","journal-title":"Arch Gen Psychiatry"},{"issue":"7","key":"jrv180006r51","doi-asserted-by":"publisher","first-page":"1352","DOI":"10.1111\/acer.2017.41.issue-7","article-title":"Pre-discharge injectable vs oral naltrexone to improve post-discharge treatment engagement among hospitalized veterans with alcohol use disorder: a randomized pilot proof-of-concept study.","volume":"41","author":"Busch","year":"2017","journal-title":"Alcohol Clin Exp Res"},{"issue":"S1","key":"jrv180006r52","first-page":"67A","article-title":"Gabapentin enacarbil extended-release for the treatment of alcohol use disorder: a multi-site, randomized, double blind, placebo-controlled trial.","volume":"42","author":"Falk","year":"2018","journal-title":"Alcohol Clin Exp Res"},{"issue":"7","key":"jrv180006r53","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1111\/add.v111.7","article-title":"Gabapentin misuse, abuse and diversion: a systematic review.","volume":"111","author":"Smith","year":"2016","journal-title":"Addiction"},{"issue":"8","key":"jrv180006r54","doi-asserted-by":"publisher","first-page":"1477","DOI":"10.1111\/add.13438","article-title":"Weak evidence on nalmefene creates dilemmas for clinicians and poses questions for regulators and researchers.","volume":"111","author":"Fitzgerald","year":"2016","journal-title":"Addiction"},{"issue":"4","key":"jrv180006r55","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1093\/alcalc\/agx030","article-title":"A randomized, placebo-controlled study of high-dose baclofen in alcohol-dependent patients: the ALPADIR Study.","volume":"52","author":"Reynaud","year":"2017","journal-title":"Alcohol Alcohol"},{"issue":"8","key":"jrv180006r56","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1177\/1060028015585849","article-title":"The role of gabapentin in the management of alcohol withdrawal and dependence.","volume":"49","author":"Leung","year":"2015","journal-title":"Ann Pharmacother"},{"issue":"2","key":"jrv180006r57","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1111\/add.v113.2","article-title":"Pharmacologically controlled drinking in the treatment of alcohol dependence or alcohol use disorders: a systematic review with direct and network meta-analyses on nalmefene, naltrexone, acamprosate, baclofen and topiramate.","volume":"113","author":"Palpacuer","year":"2018","journal-title":"Addiction"},{"issue":"1","key":"jrv180006r58","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1097\/JCP.0000000000000246","article-title":"Zonisamide, topiramate, and levetiracetam: efficacy and neuropsychological effects in alcohol use disorders.","volume":"35","author":"Knapp","year":"2015","journal-title":"J Clin Psychopharmacol"},{"issue":"3","key":"jrv180006r59","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1111\/acer.12643","article-title":"The pharmacogenetics of alcohol use disorder.","volume":"39","author":"Jones","year":"2015","journal-title":"Alcohol Clin Exp Res"},{"key":"jrv180006r61","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/1940-0640-8-12","article-title":"Prescription of topiramate to treat alcohol use disorders in the Veterans Health Administration.","volume":"8","author":"Del Re","year":"2013","journal-title":"Addict Sci Clin Pract"},{"key":"jrv180006r62","first-page":"CD004148","article-title":"Effectiveness of brief alcohol interventions in primary care populations.","volume":"2","author":"Kaner","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"issue":"10129","key":"jrv180006r64","doi-asserted-by":"publisher","first-page":"1513","DOI":"10.1016\/S0140-6736(18)30134-X","article-title":"Risk thresholds for alcohol consumption: combined analysis of individual-participant data for 599?912 current drinkers in 83 prospective studies.","volume":"391","author":"Wood","year":"2018","journal-title":"Lancet"},{"issue":"5","key":"jrv180006r65","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1097\/jcp.0b013e31814ce50d","article-title":"Efficacy of extended-release naltrexone in alcohol-dependent patients who are abstinent before treatment.","volume":"27","author":"O\u2019Malley","year":"2007","journal-title":"J Clin Psychopharmacol"},{"issue":"3","key":"jrv180006r66","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1097\/01.jcp.0000084030.22282.6d","article-title":"Targeted naltrexone for early problem drinkers.","volume":"23","author":"Kranzler","year":"2003","journal-title":"J Clin Psychopharmacol"},{"issue":"4","key":"jrv180006r67","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1176\/appi.ajp.2013.13081014","article-title":"Topiramate treatment for heavy drinkers: moderation by a GRIK1 polymorphism.","volume":"171","author":"Kranzler","year":"2014","journal-title":"Am J Psychiatry"},{"key":"jrv180006r4","doi-asserted-by":"crossref","DOI":"10.1176\/appi.books.9780890425596","volume-title":"Diagnostic and Statistical Manual of Mental Disorders","author":"American Psychiatric Association","year":"2013","edition":"5th ed"},{"key":"jrv180006r5","volume-title":"Global Status Report on Alcohol and Health","author":"World Health Organization","year":"2014"},{"key":"jrv180006r9","first-page":"387","volume-title":"Clinical Manual of Addiction Psychopharmacology","author":"Petry","year":"2014","edition":"2nd ed"},{"key":"jrv180006r28","volume-title":"Neurobiology of Alcohol Dependence","author":"Noronha","year":"2014"},{"key":"jrv180006r29","volume-title":"Clinical Manual of Addiction Psychopharmacology","author":"Kranzler","year":"2014","edition":"2nd ed"},{"key":"jrv180006r47","volume-title":"Alcoholism: Developing Drugs for Treatment Guidance for Industry","author":"US Department of Health and Human Services; Food and Drug Administration; Center for Drug Evaluation and Research (CDER)","year":"2015"},{"key":"jrv180006r1","unstructured":"Center for Behavioral Health Statistics and Quality. Results from the 2016 National Survey on Drug Use and Health: detailed tables. https:\/\/www.samhsa.gov\/data\/sites\/default\/files\/NSDUH-DetTabs-2016\/NSDUH-DetTabs-2016.pdf. Accessed June 16, 2018."},{"key":"jrv180006r2","unstructured":"Centers for Disease Control and Prevention (CDC). Alcohol and public health: alcohol-related disease impact (ARDI): average for United States 2006-2010: alcohol-attributable deaths due to excessive alcohol use. https:\/\/nccd.cdc.gov\/DPH_ARDI\/Default\/Report.aspx?T=AAM&P=f6d7eda7-036e-4553-9968-9b17ffad620e&R=d7a9b303-48e9-4440-bf47-070a4827e1fd&M=8E1C5233-5640-4EE8-9247-1ECA7DA325B9&F=&D. Accessed April 19, 2018."},{"key":"jrv180006r3","unstructured":"Centers for Disease Control and Prevention. Excessive drinking is draining the US economy. https:\/\/www.cdc.gov\/features\/costsofdrinking\/index.html. Accessed April 19, 2018."},{"key":"jrv180006r37","unstructured":"Substance Abuse and Mental Health Services Administration (SAMHSA). Receipt of services for substance use and mental health issues among adults: results from the 2015 National Survey on Drug Use and Health.https:\/\/www.samhsa.gov\/data\/sites\/default\/files\/NSDUH-ServiceUseAdult-2015\/NSDUH-ServiceUseAdult-2015\/NSDUH-ServiceUseAdult-2015.htm. Accessed June 5, 2018."},{"key":"jrv180006r60","unstructured":"Department of Veterans Affairs\/Department of Defense. VA\/DoD clinical practice guideline for the management of substance use disorders. https:\/\/www.healthquality.va.gov\/guidelines\/MH\/sud\/VADoDSUDCPGFinal1.pdf. Accessed April 21, 2018."},{"key":"jrv180006r63","unstructured":"US Department of Health and Human Services; US Department of Agriculture. Dietary guidelines for Americans 2015-2020. 8th edition. December 2015. http:\/\/health.gov\/dietaryguidelines\/2015\/guidelines\/. Accessed June 30, 2018."}],"container-title":["JAMA"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jama\/fullarticle\/2698498","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,6]],"date-time":"2025-07-06T14:31:06Z","timestamp":1751812266000},"score":1,"resource":{"primary":{"URL":"http:\/\/jama.jamanetwork.com\/article.aspx?doi=10.1001\/jama.2018.11406"}},"subtitle":["A Review"],"short-title":[],"issued":{"date-parts":[[2018,8,28]]},"references-count":67,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2018,8,28]]}},"URL":"https:\/\/doi.org\/10.1001\/jama.2018.11406","relation":{},"ISSN":["0098-7484"],"issn-type":[{"value":"0098-7484","type":"print"}],"subject":[],"published":{"date-parts":[[2018,8,28]]}}}